153 related articles for article (PubMed ID: 9182853)
1. Characterization of mechanisms of interleukin-6 gene repression by estrogen receptor.
Kurebayashi S; Miyashita Y; Hirose T; Kasayama S; Akira S; Kishimoto T
J Steroid Biochem Mol Biol; 1997 Jan; 60(1-2):11-7. PubMed ID: 9182853
[TBL] [Abstract][Full Text] [Related]
2. Involvement of CCAAT/enhancer-binding protein and nuclear factor-kappa B binding sites in interleukin-6 promoter inhibition by estrogens.
Galien R; Evans HF; Garcia T
Mol Endocrinol; 1996 Jun; 10(6):713-22. PubMed ID: 8776731
[TBL] [Abstract][Full Text] [Related]
3. Repression of interleukin-6 gene expression by 17 beta-estradiol: inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor.
Ray P; Ghosh SK; Zhang DH; Ray A
FEBS Lett; 1997 Jun; 409(1):79-85. PubMed ID: 9199508
[TBL] [Abstract][Full Text] [Related]
4. Down-modulation of interleukin-6 gene expression by 17 beta-estradiol in the absence of high affinity DNA binding by the estrogen receptor.
Ray A; Prefontaine KE; Ray P
J Biol Chem; 1994 Apr; 269(17):12940-6. PubMed ID: 8175711
[TBL] [Abstract][Full Text] [Related]
5. Role of estrogen receptor ligand and estrogen response element sequence on interaction with chicken ovalbumin upstream promoter transcription factor (COUP-TF).
Klinge CM
J Steroid Biochem Mol Biol; 1999 Nov; 71(1-2):1-19. PubMed ID: 10619353
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB site.
Galien R; Garcia T
Nucleic Acids Res; 1997 Jun; 25(12):2424-9. PubMed ID: 9171095
[TBL] [Abstract][Full Text] [Related]
7. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta.
Stein B; Yang MX
Mol Cell Biol; 1995 Sep; 15(9):4971-9. PubMed ID: 7651415
[TBL] [Abstract][Full Text] [Related]
8. Induction of interleukin (IL)-6 by hypoxia is mediated by nuclear factor (NF)-kappa B and NF-IL6 in cardiac myocytes.
Matsui H; Ihara Y; Fujio Y; Kunisada K; Akira S; Kishimoto T; Yamauchi-Takihara K
Cardiovasc Res; 1999 Apr; 42(1):104-12. PubMed ID: 10435001
[TBL] [Abstract][Full Text] [Related]
9. 4-hydroxytamoxifen trans-represses nuclear factor-kappa B activity in human osteoblastic U2-OS cells through estrogen receptor (ER)alpha, and not through ER beta.
Quaedackers ME; Van Den Brink CE; Wissink S; Schreurs RH; Gustafsson JA; Van Der Saag PT; Van Der Burg BB
Endocrinology; 2001 Mar; 142(3):1156-66. PubMed ID: 11181531
[TBL] [Abstract][Full Text] [Related]
10. [Synergism between transcription factors NF-IL6 and NF-kappa B in IL-6 gene regulation].
Fujikawa K
Hokkaido Igaku Zasshi; 1992 Jul; 67(4):563-74. PubMed ID: 1427600
[TBL] [Abstract][Full Text] [Related]
11. Constitutive activation of transcription factors NF-(kappa)B, AP-1, and NF-IL6 in human head and neck squamous cell carcinoma cell lines that express pro-inflammatory and pro-angiogenic cytokines.
Ondrey FG; Dong G; Sunwoo J; Chen Z; Wolf JS; Crowl-Bancroft CV; Mukaida N; Van Waes C
Mol Carcinog; 1999 Oct; 26(2):119-29. PubMed ID: 10506755
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor inhibits interleukin-6 gene expression by disruption of nuclear factor kappaB transactivation.
Liu H; Liu K; Bodenner DL
Cytokine; 2005 Aug; 31(4):251-7. PubMed ID: 16043358
[TBL] [Abstract][Full Text] [Related]
13. Synergistic regulation of inducible nitric oxide synthase gene by CCAAT/enhancer-binding protein beta and nuclear factor-kappaB in hepatocytes.
Sakitani K; Nishizawa M; Inoue K; Masu Y; Okumura T; Ito S
Genes Cells; 1998 May; 3(5):321-30. PubMed ID: 9685183
[TBL] [Abstract][Full Text] [Related]
14. Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: role of estrogen receptor Sp1 complex formation.
Duan R; Porter W; Safe S
Endocrinology; 1998 Apr; 139(4):1981-90. PubMed ID: 9528985
[TBL] [Abstract][Full Text] [Related]
15. Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8.
Matsusaka T; Fujikawa K; Nishio Y; Mukaida N; Matsushima K; Kishimoto T; Akira S
Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10193-7. PubMed ID: 8234276
[TBL] [Abstract][Full Text] [Related]
16. 17 beta-estradiol- and 4-hydroxytamoxifen-induced transactivation in breast, endometrial and liver cancer cells is dependent on ER-subtype, cell and promoter context.
Castro-Rivera E; Safe S
J Steroid Biochem Mol Biol; 2003 Jan; 84(1):23-31. PubMed ID: 12648521
[TBL] [Abstract][Full Text] [Related]
17. Effects of IL-10 and IL-4 on LPS-induced transcription factors (AP-1, NF-IL6 and NF-kappa B) which are involved in IL-6 regulation.
Dokter WH; Koopmans SB; Vellenga E
Leukemia; 1996 Aug; 10(8):1308-16. PubMed ID: 8709636
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of the interleukin-6 gene in mesangial cells.
Grassl C; Luckow B; Schlöndorff D; Dendorfer U
J Am Soc Nephrol; 1999 Jul; 10(7):1466-77. PubMed ID: 10405202
[TBL] [Abstract][Full Text] [Related]
19. Determining the transrepression activity of xenoestrogen on nuclear factor-kappa B in Cos-1 cells by estrogen receptor-alpha.
Ansari RA; Gandy J
Int J Toxicol; 2007; 26(5):441-9. PubMed ID: 17963131
[TBL] [Abstract][Full Text] [Related]
20. The quinone reductase gene: a unique estrogen receptor-regulated gene that is activated by antiestrogens.
Montano MM; Katzenellenbogen BS
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2581-6. PubMed ID: 9122238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]